SBIR Phase II: A Novel Respiratory Bag-Valve-Mask Resuscitator

SBIR 第二阶段：新型呼吸袋-瓣膜-面罩复苏器

• 批准号: 2242331
• 负责人: Adam Scott
• 金额: $ 99.99万
• 依托单位: COMPACT MEDICAL SOLUTIONS LLC
• 依托单位国家: 美国
• 项目类别: Cooperative Agreement
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-11-01 至 2025-10-31
• 项目状态: 未结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2242331&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Novel; Respiratory

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is a novel device which reduces injury to patients by emergency personnel when using a bag-valve-mask (BVM) manual resuscitator. BVMs are used in pre-hospital and hospital settings by emergency medical personnel on a daily basis to deliver air to critically ill patients. Their basic design has been in place for over 60 years and are often misused resulting in damage, complications, or occasionally fatal lung injury. This project will complete development of a novel BVM that precisely controls the volumes and pressures delivered, and aims to redefine the stagnant BVM market which is projected to surpass $750M annually by 2025.This Small Business Innovation Research (SBIR) Phase II project develops a novel, adjustable, universal bag-valve-mask resuscitator enabling emergency providers to deliver air volumes and pressures customized to patient body size. Current devices are commonly misused, even by highly trained medical personnel, resulting in hyperventilation, barotrauma, and occasional death. The project will complete remaining design and testing tasks, and a human factors proof of concept study to demonstrate users are able to quickly and properly utilize the device with minimal instruction will be performed. The second objective will address manufacturability and testing requirements within standards for US approval. Finally, the third objective is to establish the assembly processes and initial quality control testing to ensure consistent manufacturing at scale and in a cost effective and quality consistent manner.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这项小型企业创新研究（SBIR）II期项目的更广泛的影响/商业潜力是一种新型设备，在使用袋式阀门（BVM）手动复苏器时，可以减少急诊人员对患者的伤害。急诊医务人员每天将BVM用于院前和医院环境中，以向重症患者提供空气。它们的基本设计已经进行了60多年，并且经常被滥用，导致损害，并发症或偶尔致命的肺部受伤。该项目将完成一个新型BVM的开发，该新型BVM精确控制交付的量和压力，并旨在重新定义停滞的BVM市场，预计到2025年，该市场将每年超过7.5亿美元，到2025年。这项小型企业创新研究（SBIR）II期项目将开发出一个可调，可调节的，通用的袋装及其范围的病人，以供应范围，以供应范围，以供应范围，以供应范围，以供应范围的范围，以供应范围范围范围范围，以供应范围范围范围供应范围，以供应范围范围供应范围驱动器供应商范围内的范围驱动器供应商者供应商提供服务。 尺寸。当前的设备通常会被滥用，即使是受过高训练的医务人员，也导致过度换气，Barotrauma和偶尔死亡。该项目将完成剩余的设计和测试任务，并进行人为因素的概念证明，以证明用户能够通过最少的指导快速，正确地利用该设备。第二个目标将解决美国批准标准内的制造性和测试要求。最后，第三个目标是建立组装流程和初始质量控制测试，以确保以成本效益和质量一致的方式进行一致的制造。该奖项反映了NSF的法定任务，并被认为是值得通过基金会的知识分子的评估来支持的，并具有更广泛的影响。